top of page
  • Writer's pictureTriple Helix

Artificial Intelligence & Heart Health: A Promising Tool in Cardiovascular Disease Diagnosis

Writer: Will Boyce '25

Editor: Surya Khatri '24

The heart remains at the heart of disease, as cardiovascular disease remains the leading cause of death worldwide, claiming approximately 18.56 million lives in 2019 [2]. Diagnosing and treating cardiovascular disease is essential for improving patient outcomes and reducing the burden of this disease. Healthcare workers, including sonographers, play a critical role in assessing and diagnosing cardiovascular disease. However, the workload and demand for these professionals can be overwhelming, leading to physician burnout and potential adverse effects on patient care. Artificial intelligence (AI) has emerged as a promising tool in the healthcare field, with the potential to improve diagnostic capabilities while reducing the burden on healthcare workers.

A recent study published in Nature [2] investigated the accuracy of AI algorithms in assessing and diagnosing cardiac function in comparison with traditional methods, including echocardiogram readings performed by sonographers. The study utilized a large sample of cardiovascular data, including medical records and diagnostic test results, to train the AI algorithms. The results of the study demonstrated that AI algorithms showed promising results in predicting heart health outcomes from echocardiograms, surpassing the accuracy of professional sonographers. The AI demonstrated the potential to improve diagnostic capabilities, including the ability to identify early signs of cardiovascular disease.

The potential applications of AI in heart health assessment are vast and could lead to earlier interventions and better patient care, improving treatment strategies and patient outcomes. For example, AI-based systems could assist physicians in identifying patients who are at a higher risk of developing cardiovascular disease, allowing for earlier intervention and improved management of the disease. In addition, AI could potentially assist in identifying rare heart conditions that are often missed by traditional diagnostic methods, leading to more effective treatment strategies.

However, the researchers cautioned that further research is necessary to validate their findings. Large-scale clinical research trials and real-world implementations are critical to ensure the accuracy and reliability of AI-based cardiovascular assessments. Beyond improving the technology, ethical considerations like data privacy and bias mitigation must be thoroughly addressed in the development and implementation of AI in healthcare settings. Additionally, the integration of AI-based systems also poses a threat to healthcare workers. In the case of sonographers, the use of AI-based systems may lead to job displacement and potential loss of job opportunities. As such, it is critical to consider the potential impacts of AI on the healthcare workforce and develop strategies to address these concerns.

In conclusion, the use of AI in cardiovascular disease diagnosis shows promising results and has the potential to improve patient care while reducing the burden on healthcare workers. However, further research is necessary to validate the accuracy and reliability of AI-based cardiovascular assessments, and ethical considerations must be thoroughly addressed in the development and implementation of AI in healthcare settings. Additionally, the potential impacts of AI on the healthcare workforce must be considered and addressed to ensure a smooth transition to AI-based systems. Overall, AI-based systems have the potential to revolutionize the healthcare industry and improve patient outcomes, but careful consideration must be given to ensure that the benefits outweigh the potential risks.


Works Cited

Cardiovascular diseases (CVDs). (2021, June 11). World Health Organization. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

He, B., Kwan, A. C., Cho, J. H., Yuan, N., Pollick, C., Shiota, T., Ebinger, J., Bello, N. A., Wei, J., Josan, K., Duffy, G., Jujjavarapu, M., Siegel, R., Cheng, S., Zou, J. Y., & Ouyang, D. (2023). Blinded, randomized trial of sonographer versus AI cardiac function assessment. Nature, 616(7957), Article 7957. https://doi.org/10.1038/s41586-023-05947-3

Hospitals Utilize Artificial Intelligence to Treat Patients. (n.d.). US News & World Report. Retrieved April 23, 2023, from //www.usnews.com/news/healthcare-of-tomorrow/articles/2017-10-31/hospitals-utilize-artificial-intelligence-to-treat-patients


26 views0 comments

Comments


bottom of page